Lannett Company Inc (LCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCI | NLSP | XBIO | ||
| Company | Lannett Company Inc | Nls Pharmaceutics Ltd | Xenetic Biosciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 0.6500 | 1.9000 | 4.32 | ||
| High | 0.7196 | 2.0400 | 4.32 | ||
| Low | 0.6500 | 1.8900 | 3.98 | ||
| Last | 0.6855 | 1.9800 | 4.09 | ||
| Change | +0.0255 | +0.0300 | -0.20 | ||
| % Change | +3.86% | +1.54% | -4.66% | ||
| Volume | 280,600 | 55,900 | 8,300 | ||
| 20-Day Average Volume | 123,065 | 534,780 | 23,970 | ||
| Previous Close | 0.6600 | 1.9500 | 4.29 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1762 | 2.4305 | 4.24 | ||
| 20-Day Raw Stochastic | 3.83% | 12.56% | 23.30% | ||
| 20-Day Relative Strength | 27.93% | 34.72% | 49.54% | ||
| Weighted Alpha | -68.87 | -89.61 | +0.72 | ||
| Today's Opinion | 88% Sell | 100% Sell | 56% Buy | ||
| Previous Opinion | 88% Sell | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 40% Sell | 100% Sell | 16% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.55% since 04/12/23 | +6.45% since 12/16/24 | -0.44% since 12/16/24 | ||
| Low | 0.6375 on 04/14/23 | 1.7300 on 12/18/24 | 3.94 on 12/19/24 | ||
| High | 0.7200 on 04/14/23 | 2.7900 on 12/19/24 | 4.32 on 12/23/24 | ||
| 1-Month | |||||
| %Chg | -58.45% since 03/17/23 | -42.27% since 11/22/24 | -0.37% since 11/22/24 | ||
| Low | 0.6375 on 04/14/23 | 1.7300 on 12/18/24 | 3.92 on 12/16/24 | ||
| High | 1.8900 on 04/03/23 | 3.7200 on 11/26/24 | 4.64 on 12/05/24 | ||
| 3-Month | |||||
| %Chg | -72.78% since 01/19/23 | -63.50% since 09/23/24 | +6.03% since 09/23/24 | ||
| Low | 0.6375 on 04/14/23 | 1.7300 on 12/18/24 | 3.56 on 10/15/24 | ||
| High | 3.2500 on 02/07/23 | 5.9500 on 09/27/24 | 5.09 on 09/30/24 | ||
| 6-Month | |||||
| %Chg | -57.61% since 10/19/22 | -73.67% since 06/21/24 | -8.30% since 06/21/24 | ||
| Low | 0.6375 on 04/14/23 | 1.7300 on 12/18/24 | 2.78 on 08/06/24 | ||
| High | 3.7200 on 12/21/22 | 16.0000 on 06/27/24 | 5.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,381 | 7,439 | 6,616 | ||
| Shares Outstanding, K | 10,767 | 3,815 | 1,542 | ||
| Annual Sales | 340,580,000 | 0 | 2,540,000 | ||
| Annual Net Income | -231,620,000 | -12,170,000 | -4,130,000 | ||
| Last Quarter Sales | 80,890,000 | N/A | 610,000 | ||
| Last Quarter Net Income | -36,310,000 | N/A | -440,000 | ||
| 60-Month Beta | 0.95 | -0.52 | 2.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.36 on 02/01/23 | N/A | -0.28 on 11/12/24 | ||
| Latest Earnings Date | 05/03/23 | 08/21/24 | 11/15/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||